Small Molecule Outsourcing STREAM
-
Cambrex Scientist Spotlight: Daniel Kirschner
1/29/2025
With a Ph.D. in bioanalytical chemistry from the University of Alaska Fairbanks, Kirschner brings nearly 15 years of experience in pharmaceutical development across biotech and CDMO sectors.
-
Discovering A Unique Multimillion Euro Nanotechnology Facility
10/25/2024
Dr. David Rowe, Head of Manufacturing at Nanoform, provides an overview of Nanoform's manufacturing capabilities and introduces a new, state-of-the-art nanotechnology facility.
-
From Bench To Batch: Strategies For Scaling HPAPI Production
Highly potent materials bring additional challenges to manufacturing processes. Examine considerations for optimizing HPAPI production methods to reduce risk and deliver therapies to patients with speed.
-
Improve The Bioavailability Of Poorly Soluble Drugs
3/19/2024
KinetiSol is a fusion-based, solvent-free process that utilizes frictional and shear energies — in a fraction of the time of other amorphous solid dispersion technologies.
-
Your Journey To GMP With Emphasis On Linker Payload Development
10/22/2025
Develop lower-risk conjugation strategies by incorporating the critical insights we highlight in our review of semi-synthetic versus synthetic linker–payloads and their respective advantages and limitations.
-
OPTIMA 7000 Fill Line
6/7/2021
Ajinomoto Bio-Pharma Services is a leader in aseptic filling, offering a wide range of capabilities for vials with our OPTIMA 7000 fill line. The OPTIMA VFVM 7000 safely processes various types and classes of biopharmaceutical products in 2 mL to 100 mL sizes.
-
Cambrex Scientist Spotlight: Luigi Bellone
1/29/2025
Luigi Bellone, Head of Quality Assurance in Paullo, Milan, brings over 20 years of experience in quality assurance (QA), quality control (QC), and regulatory compliance within the pharmaceutical industry.
-
The Future Of Oral Solid Dose Development And Innovation
2/27/2025
Tom Sellig, CEO of Adare, discusses the ongoing relevance of small molecules, oral solid dose development, trends like GLP-1, and innovations like 3D printing in pharmaceuticals.
-
Improving Bioavailability, Drug Loads, And Pill Burdens Of Solid Dispersions
9/10/2024
Explore the pros and cons of marketed amorphous solid dispersions with so-far unpublished data as well as a green alternative to ASDs: best-in-class nanotechnology to manufacture nanocrystals.
-
Understanding Nitrosamines: Key Regulations And Best Practices
10/2/2024
Gain expert insights into nitrosamine regulations and discover practical strategies for ensuring compliance and safeguarding product safety.